Hjem › Kolorektal kreft › California › San Francisco
Kliniske studier for Kolorektal kreft i San Francisco, CA
18 studier for Kolorektal kreft søker deltakere på steder i og rundt San Francisco (innen ca. 30 miles). Åpne et studie for å se hvem som kan delta og hvordan du kontakter studieteamet.
Offisiell studietekst (engelsk)
Rekrutterer til et studie her? Få det fremtredende øverst på siden – $99 i 30 dager →
Symbiotic-GI-03: A Study to Learn About the Study Medicine Called PF-08634404 in Combination With Chemotherapy in Adult Participants With Metastatic Colorectal Cancer
RekruttererFase 3
- UCSF at China Basin, San Francisco
- UCSF at Mount Zion, San Francisco
- UCSF at Parnassus, San Francisco
- og 1 flere
A Study to Evaluate the Safety and Efficacy of Pumitamig in Combination With Chemotherapy Versus Bevacizumab in Combination With Chemotherapy in Participants With Previously Untreated, Unresectable, or Metastatic Colorectal Cancer
RekruttererFase 2/3
- Local Institution - 0317, San Francisco
Phase 1/2 Trial of S241656 in Selected RAS/MAPK Mutation- Positive Malignancies
RekruttererFase 1/2
- University of California, San Francisco (UCSF), San Francisco
Phase III Study of Ivonescimab or Bevacizumab Combined With FOLFOX in Patients With Metastatic Colorectal Cancer
RekruttererFase 3
- Clinical Study Site, San Francisco
A Study to Investigate the Safety, Tolerability, Pharmacokinetics, and Anti-tumor Activity of CBI-1214 T Cell Engager in Participants With Advanced or Metastatic MSS/MSI-L Colorectal Cancer
RekruttererFase 1
- UCSF, San Francisco
Tegavivint for the Treatment of Recurrent or Refractory Solid Tumors, Including Lymphomas and Desmoid Tumors
RekruttererFase 1/2
- UCSF Medical Center-Mission Bay, San Francisco
FOG-001 in Locally Advanced or Metastatic Solid Tumors
RekruttererFase 1/2
- University of California San Francisco, Helen Diller Family Comprehensive Cancer Center, San Francisco
Radiation Therapy for the Treatment of Metastatic Gastrointestinal Cancers
Rekrutterer
- University of California, San Francisco, San Francisco
A Study of MRG007 (ARR-217) in Patients With Advanced Solid Tumors
RekruttererFase 1
- UCSF, San Francisco
A Study of DM002 in Patients With Advanced Solid Tumors
RekruttererFase 1/2
- University of California San Francisco Cancer Center, San Francisco
LYL273 for Patients With Relapsed or Refractory mCRC
RekruttererFase 1/2
- University of California San Francisco Medical Center, San Francisco
BBO-11818 in Adult Subjects With KRAS Mutant Cancer
RekruttererFase 1
- University of California San Francisco Helen Diller Family Comprehensive Cancer Center, San Francisco
A Study of MGC028 in Participants With Advanced Solid Tumors
RekruttererFase 1
- UCSF - Helen Diller Family Cancer Center, San Francisco
A Study Evaluating FMC-376 in Participants With KRAS G12C Mutated Solid Tumors
RekruttererFase 1/2
- University of California San Francisco (UCSF) - Helen Diller Family Comprehensive Cancer Center, San Francisco
Assessing Benefits and Harms of Cannabis/Cannabinoid Use Among Cancer Patients Treated in Community Oncology Clinics
RekruttererObservasjonsstudie
- Kaiser Permanente-San Francisco, San Francisco
Phase 1/2 Dose Finding, Safety and PK Study in Advanced Refractory Solid Tumors
RekruttererFase 1/2
- UCSF Helen Diller Family Comprehensive Cancer Center, San Francisco
A Multicenter Cancer Biospecimen Collection Study
RekruttererObservasjonsstudie
- Curebase, San Francisco
A Study of IBI363 in Subjects with Advanced Solid Malignancies
RekruttererFase 2
- University of California, San Francisco (UCSF), San Francisco
Kolorektal kreft-studier i andre byer
- Houston, TX102 studier
- New York City, NY78 studier
- Nashville, TN69 studier
- Boston, MA63 studier
- Los Angeles, CA59 studier
- Arlington, VA52 studier
- St. Louis, MO50 studier
- San Antonio, TX46 studier
- Philadelphia, PA44 studier
- Grand Rapids, MI40 studier
- Baldwin Park, CA37 studier
- Chicago, IL34 studier
Andre studier i San Francisco
- Prostatakreft45 studier
- Brystkreft43 studier
- Ikke-småcellet lungekreft36 studier
- Kreft (alle typer)35 studier
- Hjertesvikt29 studier
- Metastatisk kreft28 studier
- Lungekreft22 studier
- Melanom22 studier
- Pankreaskreft20 studier
- Eggstokkreft19 studier
- Kardiovaskulær sykdom18 studier
- Glioblastom17 studier
Fra ClinicalTrials.gov, data hentet 6. okt. 2026. Hver studie setter sine egne kvalifikasjonskrav; studieteamet avgjør hvem som kan delta.